EICHORCondition: NSCLC · IMMUNOTHERAPY · QUANTIFICATION OF CELL-FREE DNA · Sponsor: University Hospital, Strasbourg, France
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Non-small cell lung cancer (NSCLC) is a major public health problem. New treatments as immunotherapy can improve prognosis of patients with NCLC tumors. Nevertheless, no robust biomarker is actually available. The hypothesis of the trial is to realize a longitudinal molecular monitoring of NSCLC patients treated by immunotherapy using a quantitative analysis of cell-free DNA. The primary purposes is to study the predictive value of quantification of cell-free DNA at the first reevaluation time, on the clinical benefit, in NSCLC patients treated by immunotherapy (regardless of line, or associated treatments) The secondary purposes in this population of patients is to study the earlier predictive value (before the second treatment by immunotherapy ) of quantification of cell-free DNA, and its relationship with refractory disease and pseudo-progressive disease.
This description comes directly from the study's public registry record.
BEAU-FALLER Michele, MD · +33 3 88 12 84 57 · michele.beau@chru-strasbourg.fr
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * age over 18 * informed of the objectives of the project and signed consent * non small cell lung cancer, stage IIIA, IIIB or IV * PS (WHO performance status) \< or =2 * treatment based on immunotherapy (monotherapy or combination) * at least one measurable target * available results of PD-L1 expression Exclusion Criteria: * concomitant other type of cancer * another cancer in the last 5 years
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| CHU de Besancon - Service de pneumologie | Besançon, France | Recruiting |
| Hopitaux Civils de Colmar - service de Pneumologie | Colmar, France | Recruiting |
| CHU de Dijon - service de Pneumologie | Dijon, France | Recruiting |
| CLCC Georges-François Leclerc | Dijon, France | Not Yet Recruiting |
| GHR Mulhouse Sud-Alsace - Service de Pneumologie | Mulhouse, France | Recruiting |
| CHU de Reims - service de Pneumologie | Reims, France | Recruiting |
| CHRU de Strasbourg | Strasbourg, France | Recruiting |
| Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy, France | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04720339